News Affymax, Inc.

Equities

AFFY

US00826A1097

Market Closed - OTC Markets Other stock markets 10:33:53 2024-05-09 am EDT			5-day change	1st Jan Change
0.00075 ^USD	+7.14%		+14.29%	+33.33%

2014	Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer	CI
2014	Affymax Seeks Acquisitions	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer	14-11-26	CI
Affymax Seeks Acquisitions	14-11-26	CI
Affymax, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2014	14-07-31	CI
Affymax Terminates Omontys' Product Collaboration and License Agreement with Takeda Pharmaceutical Company, Effective September 10, 2014	14-06-16	CI
Affymax and Takeda Announce Termination of Omontys(R) (peginesatide) Product Collaboration and License Agreement	14-06-13	CI
Affymax To Review Strategic Options	14-06-13	CI
Affymax, Inc. Auditor Raises 'Going Concern' Doubt	14-03-31	CI
Affymax, Inc. Executes a Seventh Amendment to Lease Agreement	13-08-20	CI
Affymax, Inc. Announces Management Changes	13-06-06	CI
Affymax, Inc.(OTCPK:AFFY) dropped from NASDAQ Composite Index	13-06-05	CI
Affymax, Inc.(OTCPK:AFFY) dropped from NASDAQ Biotechnology Index	13-05-19	CI
Affymax, Inc. to Terminate John Orwin as Chief Executive Officer After May 15, 2013	13-05-15	CI
Affymax, Inc. to Reduce Workforce Amid Product Investigation	13-04-24	CI
Affymax, Inc. Enters into a Letter Agreement with Oxford Finance Corporation and Silicon Valley Bank	13-04-04	CI
Affymax, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012	13-04-02	CI
Affymax, Inc. Auditor Raises 'Going Concern' Doubt	13-04-02	CI
Affymax Announces Reduction in Force to Align Resources Around Ongoing Product Investigation	13-03-18	CI
Affymax, Inc. may file for Bankruptcy	13-03-18	CI
Affymax Seeks Strategic Alternatives	13-03-18	CI
Transcript : Affymax, Inc. - Special Call	13-02-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Affymax, Inc.

Equities

AFFY

US00826A1097

Summary

Filters